| 000 | 01847 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516034202.0 | ||
| 264 | 0 | _c20110902 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1205-7541 | ||
| 024 | 7 |
_a10.1139/y11-020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAmmar, El-Sayed M | |
| 245 | 0 | 0 |
_aAmelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats. _h[electronic resource] |
| 260 |
_bCanadian journal of physiology and pharmacology _cApr 2011 |
||
| 300 |
_a269-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAconitine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aCreatine Kinase, MB Form _xmetabolism |
| 650 | 0 | 4 | _aDeferiprone |
| 650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aElectrocardiography _xdrug effects |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHeart Diseases _xchemically induced |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aIron _xmetabolism |
| 650 | 0 | 4 |
_aIron Chelating Agents _xpharmacology |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aPyridones _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
| 650 | 0 | 4 |
_aTachycardia, Ventricular _xchemically induced |
| 700 | 1 | _aSaid, Shehta A | |
| 700 | 1 | _aSuddek, Ghada M | |
| 700 | 1 | _aEl-Damarawy, Sally L | |
| 773 | 0 |
_tCanadian journal of physiology and pharmacology _gvol. 89 _gno. 4 _gp. 269-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1139/y11-020 _zAvailable from publisher's website |
| 999 |
_c20791592 _d20791592 |
||